551 related articles for article (PubMed ID: 30125721)
1. Mitochondria-targeting BODIPY-loaded micelles as novel class of photosensitizer for photodynamic therapy.
Li M; Li X; Cao Z; Wu Y; Chen JA; Gao J; Wang Z; Guo W; Gu X
Eur J Med Chem; 2018 Sep; 157():599-609. PubMed ID: 30125721
[TBL] [Abstract][Full Text] [Related]
2. A cyanine-derivative photosensitizer with enhanced photostability for mitochondria-targeted photodynamic therapy.
Zhao X; Yang Y; Yu Y; Guo S; Wang W; Zhu S
Chem Commun (Camb); 2019 Nov; 55(90):13542-13545. PubMed ID: 31647067
[TBL] [Abstract][Full Text] [Related]
3. Mitochondria-Targeting Selenophene-Modified BODIPY-Based Photosensitizers for the Treatment of Hypoxic Cancer Cells.
Karaman O; Almammadov T; Emre Gedik M; Gunaydin G; Kolemen S; Gunbas G
ChemMedChem; 2019 Nov; 14(22):1879-1886. PubMed ID: 31663667
[TBL] [Abstract][Full Text] [Related]
4. Novel ruthenium(ii) and iridium(iii) BODIPY dyes: insights into their application in photodynamic therapy in vitro.
Aksakal NE; Tanrıverdi Eçik E; Kazan HH; Yenilmez Çiftçi G; Yuksel F
Photochem Photobiol Sci; 2019 Aug; 18(8):2012-2022. PubMed ID: 31282525
[TBL] [Abstract][Full Text] [Related]
5. Monofunctional BODIPY-Appended Imidazoplatin for Cellular Imaging and Mitochondria-Targeted Photocytotoxicity.
Raza MK; Gautam S; Garai A; Mitra K; Kondaiah P; Chakravarty AR
Inorg Chem; 2017 Sep; 56(18):11019-11029. PubMed ID: 28846407
[TBL] [Abstract][Full Text] [Related]
6. A mitochondrion-targeted BODIPY-Ir(III) conjugate as a photoinduced ROS generator for the oxidative destruction of triple-negative breast cancer cells.
Qiao L; Liu J; Kuang S; Liao X; Kou J; Ji L; Chao H
Dalton Trans; 2021 Oct; 50(40):14332-14341. PubMed ID: 34558567
[TBL] [Abstract][Full Text] [Related]
7. A glutathione-responsive photosensitizer with fluorescence resonance energy transfer characteristics for imaging-guided targeting photodynamic therapy.
Cao JJ; Zhang MS; Li XQ; Yang DC; Xu G; Liu JY
Eur J Med Chem; 2020 May; 193():112203. PubMed ID: 32197150
[TBL] [Abstract][Full Text] [Related]
8. A water soluble carbazolyl-BODIPY photosensitizer with an orthogonal D-A structure for photodynamic therapy in living cells and zebrafish.
Wang C; Qian Y
Biomater Sci; 2020 Feb; 8(3):830-836. PubMed ID: 31790094
[TBL] [Abstract][Full Text] [Related]
9. Pyriplatin-Boron-Dipyrromethene Conjugates for Imaging and Mitochondria-Targeted Photodynamic Therapy.
Raza MK; Gautam S; Howlader P; Bhattacharyya A; Kondaiah P; Chakravarty AR
Inorg Chem; 2018 Nov; 57(22):14374-14385. PubMed ID: 30376306
[TBL] [Abstract][Full Text] [Related]
10. A novel distyryl boron dipyrromethene with two functional tags for site-specific bioorthogonal photosensitisation towards targeted photodynamic therapy.
Guo X; Wong RCH; Zhou Y; Ng DKP; Lo PC
Chem Commun (Camb); 2019 Nov; 55(90):13518-13521. PubMed ID: 31608902
[TBL] [Abstract][Full Text] [Related]
11. A CuS- and BODIPY-loaded nanoscale covalent organic framework for synergetic photodynamic and photothermal therapy.
Dong XJ; Li WY; Guan Q; Li YA; Dong YB
Chem Commun (Camb); 2022 Feb; 58(14):2387-2390. PubMed ID: 35081192
[TBL] [Abstract][Full Text] [Related]
12. Multifunctional Organic Fluorescent Probe with Aggregation-Induced Emission Characteristics: Ultrafast Tumor Monitoring, Two-Photon Imaging, and Image-Guide Photodynamic Therapy.
Ma H; Zhao C; Meng H; Li R; Mao L; Hu D; Tian M; Yuan J; Wei Y
ACS Appl Mater Interfaces; 2021 Feb; 13(7):7987-7996. PubMed ID: 33560829
[TBL] [Abstract][Full Text] [Related]
13. Curcumin "Drug" Stabilized in Oxidovanadium(IV)-BODIPY Conjugates for Mitochondria-Targeted Photocytotoxicity.
Bhattacharyya U; Kumar B; Garai A; Bhattacharyya A; Kumar A; Banerjee S; Kondaiah P; Chakravarty AR
Inorg Chem; 2017 Oct; 56(20):12457-12468. PubMed ID: 28972748
[TBL] [Abstract][Full Text] [Related]
14. BODIPY-attached zinc(II) complexes of curcumin drug for visible light assisted photo-sensitization, cellular imaging and targeted PDT.
Bhattacharyya A; Jameei A; Karande AA; Chakravarty AR
Eur J Med Chem; 2021 Aug; 220():113438. PubMed ID: 33915370
[TBL] [Abstract][Full Text] [Related]
15. Highly Phototoxic Transplatin-Modified Distyryl-BODIPY Photosensitizers for Photodynamic Therapy.
Padrutt R; Babu V; Klingler S; Kalt M; Schumer F; Anania MI; Schneider L; Spingler B
ChemMedChem; 2021 Feb; 16(4):694-701. PubMed ID: 33164336
[TBL] [Abstract][Full Text] [Related]
16. Bioengineering a Light-Responsive Encapsulin Nanoreactor: A Potential Tool for
Diaz D; Vidal X; Sunna A; Care A
ACS Appl Mater Interfaces; 2021 Feb; 13(7):7977-7986. PubMed ID: 33586952
[TBL] [Abstract][Full Text] [Related]
17. Highly efficient near-infrared BODIPY phototherapeutic nanoparticles for cancer treatment.
Zhang Y; Yang Z; Zheng X; Chen L; Xie Z
J Mater Chem B; 2020 Jun; 8(24):5305-5311. PubMed ID: 32453332
[TBL] [Abstract][Full Text] [Related]
18. Specific modification and self-transport of porphyrins and their multi-mechanism cooperative antitumor studies.
Jia S; Wang S; Li S; Hu P; Yu S; Shi J; Yuan J
J Mater Chem B; 2021 Apr; 9(14):3180-3191. PubMed ID: 33885622
[TBL] [Abstract][Full Text] [Related]
19. Biotin-decorated NIR-absorbing nanosheets for targeted photodynamic cancer therapy.
Perumal D; Golla M; Pillai KS; Raj G; Krishna P K A; Varghese R
Org Biomol Chem; 2021 Mar; 19(12):2804-2810. PubMed ID: 33720265
[TBL] [Abstract][Full Text] [Related]
20. Intracellular GSH-activated galactoside photosensitizers for targeted photodynamic therapy and chemotherapy.
Wang C; Liu L; Cao H; Zhang W
Biomater Sci; 2017 Jan; 5(2):274-284. PubMed ID: 27942618
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
